Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of Caffeine in ADCY5-Related Dyskinesia: A Retrospective Study.
Méneret A, Mohammad SS, Cif L, Doummar D, DeGusmao C, Anheim M, Barth M, Damier P, Demonceau N, Friedman J, Gallea C, Gras D, Gurgel-Giannetti J, Innes EA, Necpál J, Riant F, Sagnes S, Sarret C, Seliverstov Y, Paramanandam V, Shetty K, Tranchant C, Doulazmi M, Vidailhet M, Pringsheim T, Roze E. Méneret A, et al. Among authors: doulazmi m. Mov Disord. 2022 Jun;37(6):1294-1298. doi: 10.1002/mds.29006. Epub 2022 Apr 5. Mov Disord. 2022. PMID: 35384065
Non cell-autonomous role of DCC in the guidance of the corticospinal tract at the midline.
Welniarz Q, Morel MP, Pourchet O, Gallea C, Lamy JC, Cincotta M, Doulazmi M, Belle M, Méneret A, Trouillard O, Ruiz M, Brochard V, Meunier S, Trembleau A, Vidailhet M, Chédotal A, Dusart I, Roze E. Welniarz Q, et al. Among authors: doulazmi m. Sci Rep. 2017 Mar 24;7(1):410. doi: 10.1038/s41598-017-00514-z. Sci Rep. 2017. PMID: 28341853 Free PMC article.
Mutations in the netrin-1 gene cause congenital mirror movements.
Méneret A, Franz EA, Trouillard O, Oliver TC, Zagar Y, Robertson SP, Welniarz Q, Gardner RJM, Gallea C, Srour M, Depienne C, Jasoni CL, Dubacq C, Riant F, Lamy JC, Morel MP, Guérois R, Andreani J, Fouquet C, Doulazmi M, Vidailhet M, Rouleau GA, Brice A, Chédotal A, Dusart I, Roze E, Markie D. Méneret A, et al. Among authors: doulazmi m. J Clin Invest. 2017 Nov 1;127(11):3923-3936. doi: 10.1172/JCI95442. Epub 2017 Sep 25. J Clin Invest. 2017. PMID: 28945198 Free PMC article.
A randomized, controlled, double-blind, crossover trial of triheptanoin in alternating hemiplegia of childhood.
Hainque E, Caillet S, Leroy S, Flamand-Roze C, Adanyeguh I, Charbonnier-Beaupel F, Retail M, Le Toullec B, Atencio M, Rivaud-Péchoux S, Brochard V, Habarou F, Ottolenghi C, Cormier F, Méneret A, Ruiz M, Doulazmi M, Roubergue A, Corvol JC, Vidailhet M, Mochel F, Roze E. Hainque E, et al. Among authors: doulazmi m. Orphanet J Rare Dis. 2017 Oct 2;12(1):160. doi: 10.1186/s13023-017-0713-2. Orphanet J Rare Dis. 2017. PMID: 28969699 Free PMC article. Clinical Trial.
Health-Related Quality of Life Is Severely Affected in Primary Orthostatic Tremor.
Maugest L, McGovern EM, Mazalovic K, Doulazmi M, Apartis E, Anheim M, Bourdain F, Benchetrit E, Czernecki V, Broussolle E, Bonnet C, Falissard B, Jahanshahi M, Vidailhet M, Roze E. Maugest L, et al. Among authors: doulazmi m. Front Neurol. 2018 Jan 15;8:747. doi: 10.3389/fneur.2017.00747. eCollection 2017. Front Neurol. 2018. PMID: 29379467 Free PMC article.
Long-term follow-up in an open-label trial of triheptanoin in GLUT1 deficiency syndrome: a sustained dramatic effect.
Hainque E, Gras D, Meneret A, Atencio M, Luton MP, Barbier M, Doulazmi M, Habarou F, Ottolenghi C, Roze E, Mochel F. Hainque E, et al. Among authors: doulazmi m. J Neurol Neurosurg Psychiatry. 2019 Nov;90(11):1291-1293. doi: 10.1136/jnnp-2018-320283. Epub 2019 Apr 4. J Neurol Neurosurg Psychiatry. 2019. PMID: 30948626 Free PMC article. Clinical Trial. No abstract available.
Descriptive analysis of the French NS-Park registry: Towards a nation-wide Parkinson's disease cohort?
Mariani LL, Doulazmi M, Chaigneau V, Brefel-Courbon C, Carrière N, Danaila T, Defebvre L, Defer G, Dellapina E, Doé de Maindreville A, Geny C, Maltête D, Meissner WG, Rascol O, Thobois S, Torny F, Tranchant C, Vidailhet M, Corvol JC, Degos B; NS-Park/F-CRIN Network study group. Mariani LL, et al. Among authors: doulazmi m. Parkinsonism Relat Disord. 2019 Jul;64:226-234. doi: 10.1016/j.parkreldis.2019.04.012. Epub 2019 Apr 25. Parkinsonism Relat Disord. 2019. PMID: 31047798
Long-term effect of apomorphine infusion in advanced Parkinson's disease: a real-life study.
Meira B, Degos B, Corsetti E, Doulazmi M, Berthelot E, Virbel-Fleischman C, Dodet P, Méneret A, Mariani LL, Delorme C, Cormier-Dequaire F, Bendetowicz D, Villain N, Tarrano C, Mantisi L, Letrillart H, Louapre C, McGovern E, Worbe Y, Grabli D, Vidailhet M, Hainque E, Roze E. Meira B, et al. Among authors: doulazmi m. NPJ Parkinsons Dis. 2021 Jun 11;7(1):50. doi: 10.1038/s41531-021-00194-7. NPJ Parkinsons Dis. 2021. PMID: 34117268 Free PMC article.
Safety and efficacy of subcutaneous night-time only apomorphine infusion to treat insomnia in patients with Parkinson's disease (APOMORPHEE): a multicentre, randomised, controlled, double-blind crossover study.
De Cock VC, Dodet P, Leu-Semenescu S, Aerts C, Castelnovo G, Abril B, Drapier S, Olivet H, Corbillé AG, Leclair-Visonneau L, Sallansonnet-Froment M, Lebouteux M, Anheim M, Ruppert E, Vitello N, Eusebio A, Lambert I, Marques A, Fantini ML, Devos D, Monaca C, Benard-Serre N, Lacombe S, Vidailhet M, Arnulf I, Doulazmi M, Roze E. De Cock VC, et al. Among authors: doulazmi m. Lancet Neurol. 2022 May;21(5):428-437. doi: 10.1016/S1474-4422(22)00085-0. Lancet Neurol. 2022. PMID: 35429481 Clinical Trial.
54 results